<DOC>
	<DOCNO>NCT02088281</DOCNO>
	<brief_summary>The potential effect indigo naturalis immune system unknown . The investigator hypothesize therapeutic effect indigo naturalis psoriasis may involve inhibit activation Th1 Th17 cell produce pro-inflammatory cytokine , thereby regulate hyperplasia epidermis induce Th1/Th17 related cytokine .</brief_summary>
	<brief_title>Mechanistic Study Indigo Naturalis Treating Psoriasis</brief_title>
	<detailed_description>Psoriasis chronic inflammatory dermatosis induce altered interaction immune system skin characterize hyperplasia epidermis ( acanthosis ) , infiltration leukocyte dermis epidermis , dilation growth blood vessel . Our previous study show topical application indigo naturalis significantly improve psoriatic symptom demonstrate anti-psoriatic effect indigo naturalis mediate promote differentiation inhibit proliferation epidermal keratinocytes . However , potential effect indigo naturalis immune system unknown . Currently , grow evidence demonstrates activate T cell primary modulators pathogenesis psoriasis psoriasis believe mixed Th1/Th17 disease strong IL-17 interferon-γ ( IFN-γ ) signatures . The identification elevate level IFN-γ , tumor necrosis factor ( TNF-α ) , IL-12 , IL-17 IL 22 cutaneous lesion serum psoriatic patient support theory Th1/Th17-related cytokine directly indirectly act keratinocytes lead activation hyperproliferation . The investigator suppose therapeutic effect indigo naturalis psoriasis may involve inhibit activation Th1 Th17 cell produce pro-inflammatory cytokine , thereby regulate hyperplasia epidermis induce Th1/Th17 related cytokine . The aim study : 1 . To investigate whether effect indigo naturalis improve psoriatic symptom associate function Th1/Th17 cell express IFN-γ IL-17 peripheral blood patient psoriasis therapy . 2 . To investigate whether effect indigo naturalis improve psoriatic symptom associate production pro-inflammatory cytokine peripheral blood patient psoriasis therapy . 3 . To investigate whether effect indigo naturalis improve psoriatic symptom associate histopathological change psoriatic lesion whether pathological change different change inflammatory immune reaction patient psoriasis . 4 . To investigate effect Th1/Th17-related cytokine immunological factor patient indigo naturalis treatment epidermal keratinocytes . 5 . To detect effect indigo naturalis function release cytokine ( IFN-γ , IL-17 , IL-23 , etc . ) monocytes patient psoriasis . 6 . To analyze concentration indirubin peripheral blood clarify whether effect indigo naturalis improve psoriatic symptom : ( A ) systemic effect affect metabolism immune system absorption transdermal delivery body . ( B ) direct effect epidermal keratinocytes alone .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Aged 20 65 year , men woman Diagnosed plaquetype psoriasis dermatologist . Plaque psoriasis involve &lt; 20 % body surface area ( BSA ) psoriasis area severity index ( PASI ) &lt; 20 If childbearing age , negative pregnancy test screening , agreement continue use birth control measure approve investigator duration study . Willingness comply study protocol sign informed consent form . A history topically systematically sensitivity indigo naturalis component excipient . Systematic therapy psoriasis within 4 week baseline include Methotrexate ( MTX ) , immunosuppressive agent ( e.g . cyclosporine ) , retinoid ( vitamin A derivative ) , biologics ( e.g . Etanercept , Alefacept , Infliximab ) , vitamin D3 analog phototherapy . Topical therapy psoriasis within 2 week baseline include tar , corticosteroid , vitamin D3 analog , retinoid . Pustular generalize erythrodermic psoriasis . With abnormal liver renal function ( e.g . liver cirrhosis , hepatitis B/C , renal failure , creatinine &gt; 2.0 mg/dL , AST/ALT &gt; 3 x ULN ) , clinically significant abnormality hematology , severe uncontrolled metabolic syndrome ( e.g. , hypertension , diabetes mellitus , metabolic arthritis , hyperthyroidism ) , psychiatric disease , cancer AIDS . Women lactate , pregnant planning become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Indigo naturalis , indirubin , Th1 cell , Th17 cell</keyword>
</DOC>